Schedule 13G ownership disclosure
AQUINOX PHARMACEUTICALS, INC
Security class unavailable · CUSIP: 03842B101
Event date: 2015-08-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 481,529
- Percent of class
- 4.4900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000078003-15-000037
- Form type
- SC 13G
- Filer
- Neurogene Inc.
- CIK
- CIK 1404644
- Filed
- Aug 18, 2015
- Reporting period
- Aug 14, 2015
- Description
- Schedule 13G beneficial ownership